Sentinel Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-616,000
Closed -$47.9M 77
2017
Q3
$47.9M Sell
616,000
-32,320
-5% -$2.68M 1.15% 18
2017
Q2
$57.5M Sell
648,320
-56,700
-8% -$4.78M 1.39% 8
2017
Q1
$56.8M Sell
705,020
-1,300
-0.2% -$102K 1.34% 9
2016
Q4
$50.3M Buy
706,320
+6,000
+0.9% +$471K 1.26% 15
2016
Q3
$60.5M Hold
700,320
1.44% 10
2016
Q2
$60.8M Buy
700,320
+13,000
+2% +$1.05M 1.43% 6
2016
Q1
$51.5M Sell
687,320
-53,300
-7% -$4.01M 1.15% 13
2015
Q4
$57M Sell
740,620
-46,573
-6% -$3.51M 1.43% 6
2015
Q3
$52.7M Buy
787,193
+18,000
+2% +$1.33M 1.35% 9
2015
Q2
$57M Sell
769,193
-48,900
-6% -$3.74M 1.3% 8
2015
Q1
$63.8M Buy
818,093
+330,893
+68% +$25.1M 1.39% 5
2014
Q4
$35.2M Sell
487,200
-34,500
-7% -$2.4M 0.74% 48
2014
Q3
$32.3M Buy
521,700
+5,000
+1% +$318K 0.67% 56
2014
Q2
$32.9M Sell
516,700
-600
-0.1% -$36.4K 0.66% 51
2014
Q1
$31.8M Buy
517,300
+10,000
+2% +$582K 0.63% 54
2013
Q4
$29.1M Buy
507,300
+10,800
+2% +$612K 0.56% 62
2013
Q3
$26.4M Buy
496,500
+25,800
+5% +$1.39M 0.55% 68
2013
Q2
$24.2M Buy
+470,700
New +$23.3M 0.52% 66

Other funds holding MDT

Sentinel Asset Management's MDT Position: Q4 2017 in Review

Sentinel Asset Management sold out of Medtronic (MDT) in Q4 2017, closing a stake of 616,000 shares — an estimated $47.9M sold.

Sentinel Asset Management first reported a position in MDT in Q2 2013 and held it in 18 quarters. The position peaked at $63.8M in Q1 2015. 1,408 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

  • Sentinel Asset Management reported no remaining Medtronic position as of Q4 2017 after selling out during the quarter.
  • Sentinel Asset Management sold 616,000 Medtronic shares in Q4 2017, an estimated $47.9M.
  • Sentinel Asset Management first reported a position in Medtronic in Q2 2013 and held it in 18 quarters.
  • Sentinel Asset Management's Medtronic position peaked at $63.8M in Q1 2015.
  • 1,408 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Sentinel Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.